GLP-1 medications remain a safe and effective option for managing type 2 diabetes and obesity for the majority of the population, but its crucial to evaluate each patients risk profile before starting treatment
#Research #Type2Diabetes #CardiovascularDisease #MicroRNA #SIRT1 #PrecisionMedicine #MolecularBiology #Biomarkers #TranslationalMedicine #MedicalGenomics #DiabetesResearch #CardiovascularResearch #UFJ #Science #OpenAccess To view or add a comment, sign in This is a historic moment for RNA therapeutics, and I could not be prouder of the Ractigen team
Modified GRF 1-29 & Ipamorelin and Muscle Cells Research suggests that growth hormone-secretagogues, of which Ipamorelin is classified, may inhibit the catabolic activity of glucocorticoids on muscles (such as muscle wasting)
doi:10.3945/jn.115.211888 Suzuki-Sugihara N, Kishimoto Y, Saita E, et al
Unfortunately this current model cannot be used on permanent make-up